Adeona Pharmaceuticals
-
Adeona Pharmaceuticals pulls in $1M equity investment
Adeona Pharmaceuticals (AMEX: AEN) has received a $1 million equity investment from a Florida private […]
-
Q&A with Adeona Pharmaceuticals’ new chief executive
The last couple years have been a bumpy ride for Adeona Pharmaceuticals. The company nearly […]
-
Streamline the Process for Consent Collection and Management
Join us on April 16th and hear executives from DocuSign and Velatura discuss how their partnership modernizes and facilitates the efficient and secure completion of the patient consent form.
-
Michigan’s Adeona reaches halfway point in enrollment for multiple sclerosis trials
Adeona Pharmaceuticals has enrolled half of the patients it hopes to sign up for trials of its multiple sclerosis drug Trimesta. The company is in the midst of what it calls Phase “2/3” trials of Trimesta and has enrolled 75 of a planned 150 patients.
-
Michigan’s Adeona Pharmaceuticals hires second CEO in less than a year
For the second time in less than a year, Adeona Pharmaceuticals has hired a new chief executive. Dr. James Kuo, who’s served on the company’s board since 2007, takes over as the company’s CEO, president and chairman of the board.